Diagnosis of cytomegalovirus pneumonia by quantitative polymerase chain reaction using bronchial washing fluid from patients with hematologic malignancies-Reference-Cited by-同舟云学术

Diagnosis of cytomegalovirus pneumonia by quantitative polymerase chain reaction using bronchial washing fluid from patients with hematologic malignancies

Published:2017-01-04 Issue:24 Volume:8 Page:39736-39745
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Lee Hwa Young¹,Rhee Chin Kook¹,Choi Joon Young¹,Lee Hea Yon¹,Lee Jong Wook²³,Lee Dong Gun³⁴⁵

Affiliation:

1. Department of Internal Medicine, Division of Pulmonary and Critical Care Medicine, The Catholic University of Korea, Seoul, Korea

2. Department of Internal Medicine, Division of Hematology, The Catholic University of Korea, Seoul, Korea

3. The Catholic Blood and Marrow Transplantation Center, The Catholic University of Korea, Seoul, Korea

4. Department of Internal Medicine, Division of Infectious Diseases, The Catholic University of Korea, Seoul, Korea

5. Vaccine Bio Research Institute, The Catholic University of Korea, Seoul, Korea

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Consensus Definitions of Cytomegalovirus (CMV) Infection and Disease in Transplant Patients Including Resistant and Refractory CMV for Use in Clinical Trials: 2024 Update From the Transplant Associated Virus Infections Forum;Clinical Infectious Diseases;2024-07-23

2. Pulmonary herpes simplex virus and cytomegalovirus in patients with acute respiratory distress syndrome related to COVID-19;Intensive Care Medicine;2024-07-17

3. Performance evaluation of the Alinity m system for quantifying cytomegalovirus DNA in samples of the respiratory, gastrointestinal, and urinary tract;Microbiology Spectrum;2024-07-02

4. Evaluation of Alinity m CMV assay performance for detecting CMV in plasma, cerebrospinal fluid, and bronchoalveolar lavage specimens;Diagnostic Microbiology and Infectious Disease;2024-07

5. Advantages of metagenomic next-generation sequencing in the management of ANCA-associated vasculitis patients with pulmonary infections as a rule-out tool;2024-03-21